What Retail Traders Really Think About Hawaiian Electric
The Maui wildfires has put a focus on Hawaiian Electric and the volatility of its stock.
EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers
Plus Therapeutics Inc (NASDAQ: PSTV) has expanded its supply agreement with Biocept Inc (NASDAQ: BIOC) by acquiring an option to exclusively license Biocept's CNSide, a cerebrospinal flu
EXCLUSIVE: Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics
Lineage Cell Therapeutics Inc (NYSE: LCTX) has initiated certain development activities to generate a novel hypoimmune induced pluripotent stem cell (iPSC) line under the company’s exclusive option and license agreement with Eterna Therapeutics Inc (NASDAQ:
China Rallies, Europe Dips: US Market Outlook For Labor Day-Shortened Week
While the U.S. markets are closed for the Labor Day holiday, the announcement of stimulus measures in China…
Weed Stocks Skyrocket, Could There Be More Upside? Analyst Draws Scenarios
The Department of Health and Human Services (HHS) suggested the DEA reclassify cannabis as a Schedule III controlled substance under federal law. Assistant Secretary for Health Rachel Levine's
EXCLUSIVE: Psychedelics Co. Closes $7.5M Financing – Here’s Its Secret To Raising Millions In A Tough Environment
In the bustling heart of Miami, amidst the buzz of the Benzinga Cannabis and Psychedelics Capital Conference, a pivotal conversation ignited a partnership destined to revolutionize the world of wellness.
EXCLUSIVE: Lancaster Resources to Acquire Lithium Project in Quebec’s Prolific James Bay Region
Lancaster Resources Inc (OTC: LANRF) on August 29, 2023, agreed to replace the Letter of Intent entered into on July 23, 2023 to acquire 100% of the Trans Taiga Lithium Project (Property) in the Eeyou Istchee James Bay region of Quebec.
EXCLUSIVE: Diagnostics Provider Avalon GloboCare’s Subsidiary Launches New Laboratory Test For Tuberculosis
Avalon GloboCare Corp (NASDAQ: ALBT) announced that Laboratory Services MSO (LSM) is now offering an in-house laboratory-developed test to detect tuberculosis using a patient’s sputum sample.
Avalon owns a 40% interest in Laboratory Services (LSM).
EXCLUSIVE: Alzamend Seeks FDA Approval For Study For Upgraded Version Of Most Commonly Used Treatment For Bipolar Disorder
Alzamend Neuro Inc (NASDAQ: ALZN) has submitted an investigational new drug (IND) application to the FDA to initiate AL001-BD01, a Phase 2A study of AL001 for bipolar disorder.
Canadian Cannabis Flower Power: Who Are The Top Players? What Happened In Q2 2023?
Zuanic & Associates' recent report unveils the movers and shakers in the flower segment, shedding light on their market shares, pricing strategies and fortunes. The second quarter of 2023 saw some intriguing shifts in the sector.